Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 614 clinical trials
featured
Atrial Fibrillation

of ischemic stroke or systemic embolism in subjects with non-valvular atrial fibrillation who have an appropriate rationale to seek a non-pharmacologic alternative to chronic oral anticoagulation.

heart failure
warfarin
vascular disease
cardioversion
warfarin therapy
  • 618 views
  • 03 Dec, 2020
  • 1 location
featured
Heart Valve Disease – Aortic and Mitral

Study Description: Multi-center, international, prospective, randomized, interventional, pre-market study. Patients will be seen at pre and post-procedure, discharge, 30 days, 6 months, 1 year, 18 months, and annually through 10 years. Randomly assigned (50% to either group) Treatment of Aortic Stenosis with either Transcatheter Aortic Valve Replacement (TAVR) device or …

stenosis
aortic valve replacement
  • 776 views
  • 05 Feb, 2021
  • 1 location
featured
Evaluation of the VISITAG SURPOINT™ Module with External Processing Unit (EPU) when used with the THERMOCOOL SMARTTOUCH® SF and the THERMOCOOL SMARTTOUCH® Catheters for Pulmonary Vein Isolation (PVI) (SURPOINT COA)

Prospective, non-randomized, post market clinical evaluation of the VISITAG SURPOINT™ Module with External Processing Unit (EPU) when used with STSF catheter and ST catheter compared to an historical control performance goal. A maximum of 330 subjects will be enrolled across up to 45 sites. Two hundred eighty (280) enrolled subjects …

antiarrhythmic drug
holter monitor
electrocardiogram
atrial fibrillation
  • 104 views
  • 24 Nov, 2020
  • 1 location
featured
Evaluation of QDOT MICRO™ catheter for pulmonary vein isolation (PVI) in subjects with Paroxysmal Atrial Fibrillation (PAF) Protocol# BWI_2017_07

The purpose of this study is to provide information about the safety and long-term effectiveness of the QDOT MICRO™ Catheter for the treatment of subjects with Paroxysmal Atrial Fibrillation

heart failure
heparin
antiarrhythmic drug
anticoagulation therapy
catheter ablation
  • 51 views
  • 24 Nov, 2020
  • 1 location
featured
Assessment of the WATCHMANTM Device in Patients Unsuitable for Oral Anticoagulation ASAP-TOO

Assessment of the WATCHMANTM Device in Patients Unsuitable for Oral Anticoagulation ASAP-TOO

heart failure
vascular disease
cardioversion
aspirin
stroke
  • 408 views
  • 03 Dec, 2020
  • 1 location
featured
Apixaban for the Reduction of Thrombo-Embolism in patients with Device-Detected Sub- Clinical Atrial fibrillation (ARTESiA)

Apixaban for the Reduction of Thrombo-Embolism in patients with Device-Detected Sub- Clinical Atrial fibrillation (ARTESiA)

vascular disease
cardiac monitoring
stroke
atrial fibrillation
diabetes
  • 314 views
  • 24 Nov, 2020
  • 1 location
featured
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

  • 82 views
  • 23 Nov, 2020
  • 1 location
featured
  • 88 views
  • 08 Nov, 2020
  • 1 location
featured
GENETIC-AF: A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure

GENETIC-AF: A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure

  • 452 views
  • 08 Nov, 2020
  • 1 location